DRUG
BRIGHT MINDS BIOSCIENCES INC.
$65.28
-5.39%
$640.5M
No data for this timeframe.
Vol
Market Cap$640.5M
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (86%)
Inst. Holders7 funds
Inst. Value$17.0M
Inst. Activity3 buys / 3 sells
Insider Activity0B / 1S
Insider Net $-$9.8M
Reddit Sentiment42° Neutral
SEC Reports2
Recent Activity
Jun 3, 2026
SEC
Bright Minds Biosciences filed its management information circular for the March 31, 2026 annual general meeting. The ci
6-K — Impact 2/10
Jun 2, 2026
SEC
Bright Minds Biosciences Inc. filed a Form 6-K with the SEC on June 2, 2026, providing notice of its Annual General Meet
6-K — Impact 2/10
May 26, 2026
other
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
<p>NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB
Apr 28, 2026
Insider
Cormorant Asset Management, LP sold 109,331 shares
$89.50 ($9.8M)
Inst.
MORGAN STANLEY — TRIM
132,122 shares ($10.3M)
Inst.
BANK OF AMERICA CORP — DOUBLED
15,075 shares ($1.2M)
Price Targets
$167.98
+147.8% upside
Strong Buy
Current $67.80
Low $142.25
Median $144.55
High $217.14
3 analysts
$142.25
$217.14
Analyst Ratings
3Strong Buy
3Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 1, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
| May 20, 2026 | Piper Sandler | MAINTAIN | Overweight → Overweight |
| Apr 13, 2026 | Jefferies | INITIATE | Buy |
| Mar 30, 2026 | BTIG | REITERATE | Buy → Buy |
| Mar 4, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-1.64 ▲ +3.7% | $-2.51 — $-0.76 | -121% YoY | 6 |
| Next Q | $-2.16 ▼ -1.4% | $-3.29 — $-0.41 | -272% YoY | 6 |
| Current FY | $-6.05 ▲ +11.5% | $-8.22 — $-3.20 | -240% YoY | 6 |
| Next FY | $-12.09 ▼ -13.7% | $-19.19 — $-6.24 | -100% YoY | 6 |
Latest Reports
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| MORGAN STANLEY | $10.3M | TRIM |
| VANGUARD GROUP INC | $3.8M | ADD |
| BANK OF AMERICA CORP | $1.2M | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $972.8K | NEW |
| WELLS FARGO & COMPANY/MN | $431.0K | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 28, 2026 | Cormorant Asset | SELL | $9.8M |
Reddit Sentiment
42°
Neutral
Bearish
Neutral
Bullish
7 institutional holders with $17.0M total value (217,473 shares) as of 2025-Q4. Top holders: MORGAN, VANGUARD, BANK.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY | 132,122 | $10.3M | 60.8% | TRIM -31.5% |
| 2 | VANGUARD GROUP INC | 48,576 | $3.8M | 22.3% | ADD +41.0% |
| 3 | BANK OF AMERICA CORP /DE/ | 15,075 | $1.2M | 6.9% | DOUBLED +114.2% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 12,465 | $972.8K | 5.7% | NEW |
| 5 | WELLS FARGO & COMPANY/MN | 5,523 | $431.0K | 2.5% | ADD +95.4% |
| 6 | TWO SIGMA INVESTMENTS, LP | 2,601 | $203.0K | 1.2% | NEAR_EXIT -75.7% |
| 7 | FMR LLC | 1,111 | $86.7K | 0.5% | ADD +70.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 192,866 | 132,122 | -31.5% | $10.3M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 7,037 | 15,075 | +114.2% | $1.2M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 2,826 | 5,523 | +95.4% | $431.0K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 10,711 | 2,601 | -75.7% | $203.0K | 2025-Q4 |
| FMR LLC | ADD | 651 | 1,111 | +70.7% | $86.7K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 3,500 | 0 | -100.0% | $0.00 | 2025-Q4 |
| VANGUARD GROUP INC | ADD | 31,983 | 45,103 | +41.0% | $2.7M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | NEW | — | 10,711 | — | $649.7K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 4,734 | 7,037 | +48.6% | $426.9K | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 3,500 | — | $212.3K | 2025-Q3 |
| FMR LLC | DOUBLED | 79 | 651 | +724.1% | $39.5K | 2025-Q3 |
| VANGUARD GROUP INC | NEW | — | 31,983 | — | $835.1K | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 11,604 | — | $303.0K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEW | — | 2,378 | — | $62.1K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 11,535 | 1,914 | -83.4% | $50.0K | 2025-Q2 |
| CITADEL ADVISORS LLC | NEW | — | 6,885 | — | $248.3K | 2025-Q1 |
| MORGAN STANLEY | NEW | — | 167,640 | — | $6.0M | 2024-Q4 |
| UBS Group AG | DOUBLED | 3,407 | 10,161 | +198.2% | $366.0K | 2024-Q4 |
1 unique insiders with 1 transactions. Net insider value: -$9.8M ($0.00 bought, $9.8M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Cormorant Asset Management, LP | SELL | 109,331 | $89.50 | $9.8M |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 2.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (86% buy). Based on 7 analysts: 3 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$167.98 mean target
+147.8% upside
Strong Buy (1.14)
$142.25 Low
$217.14 High
| Metric | Value |
|---|---|
| Current Price | $67.80 |
| Target Low | $142.25 |
| Target Mean | $167.98 |
| Target Median | $144.55 |
| Target High | $217.14 |
| # Analysts | 3 |
| Recommendation | Strong Buy (1.14) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-1.64 | $-2.51 | $-0.76 | -121.2% | +3.7% | 2↑ 2↓ | $0.0B | 0.0% | 6 |
| Next Q 2026-09-30 |
$-2.16 | $-3.29 | $-0.41 | -272.4% | -1.4% | 2↑ 2↓ | $0.0B | 0.0% | 6 |
| Current FY 2026-09-30 |
$-6.05 | $-8.22 | $-3.20 | -239.8% | +11.5% | 2↑ 2↓ | $0.0B | 0.0% | 6 |
| Next FY 2027-09-30 |
$-12.09 | $-19.19 | $-6.24 | -99.8% | -13.7% | 0↑ 4↓ | $0.0B | 0.0% | 6 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-1.637 | |
| 7d ago | $-1.462 | -0.175 |
| 30d ago | $-1.700 | +0.063 |
| 60d ago | $-1.638 | +0.001 |
| 90d ago | $-1.310 | -0.327 |
5 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 1, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
| May 20, 2026 | Piper Sandler | MAINTAIN | Overweight | Overweight |
| Apr 13, 2026 | Jefferies | INITIATE | — | Buy |
| Mar 30, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 4, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Feb 17, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 7, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 6, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 2, 2026 | Chardan Capital | MAINTAIN | Buy | Buy |
| Dec 30, 2025 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Oct 1, 2022 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Sep 1, 2022 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Aug 1, 2022 | 3 | 3 | 1 | 0 | 0 | 86% | |
| Jul 1, 2022 | 3 | 3 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
42°
Neutral
Bearish
Neutral
Bullish
2 mentions
0 bullish
1 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 7, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| Oct 16, 2024 | 1 | 40° Cool | 0 | 1 | 1 |
Recent Reddit Threads
May 26, 2026
other
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference
<p>NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering c
Apr 8, 2026
short_interest
FTD: DRUG — 7,919 shares ($0.6M) failed to deliver
Settlement: 20260408, Price: $76.87, FTD Value: $608,733.53, BRIGHT MINDS BIOSCIENCES INC C